Assenagon Asset Management’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15M | Buy |
237,998
+215,806
| +972% | +$13.6M | 0.02% | 375 |
|
|
2025
Q1 | $1.18M | Buy |
+22,192
| New | +$1.18M | ﹤0.01% | 845 |
|
|
2024
Q4 | – | Sell |
-20,052
| Closed | -$1.05M | – | 1397 |
|
|
2024
Q3 | $1.05M | Sell |
20,052
-209,439
| -91% | -$11M | ﹤0.01% | 1095 |
|
|
2024
Q2 | $9.42M | Sell |
229,491
-56,160
| -20% | -$2.31M | 0.02% | 426 |
|
|
2024
Q1 | $12.4M | Sell |
285,651
-15,985
| -5% | -$693K | 0.03% | 352 |
|
|
2023
Q4 | $13.9M | Sell |
301,636
-105,654
| -26% | -$4.86M | 0.04% | 345 |
|
|
2023
Q3 | $9.34M | Sell |
407,290
-135,920
| -25% | -$3.12M | 0.03% | 376 |
|
|
2023
Q2 | $8.96M | Sell |
543,210
-120,816
| -18% | -$1.99M | 0.03% | 357 |
|
|
2023
Q1 | $11.8M | Buy |
664,026
+200,510
| +43% | +$3.58M | 0.04% | 325 |
|
|
2022
Q4 | $13.5M | Sell |
463,516
-6,894
| -1% | -$201K | 0.05% | 299 |
|
|
2022
Q3 | $11.5M | Sell |
470,410
-219,310
| -32% | -$5.37M | 0.04% | 297 |
|
|
2022
Q2 | $2.86M | Sell |
689,720
-16,200
| -2% | -$67.2K | 0.01% | 684 |
|
|
2022
Q1 | $8.13M | Buy |
705,920
+21,174
| +3% | +$244K | 0.02% | 390 |
|
|
2021
Q4 | $6.83M | Buy |
684,746
+182,476
| +36% | +$1.82M | 0.02% | 401 |
|
|
2021
Q3 | $6.56M | Buy |
502,270
+359,798
| +253% | +$4.7M | 0.02% | 324 |
|
|
2021
Q2 | $2.79M | Buy |
+142,472
| New | +$2.79M | 0.01% | 572 |
|